Lundeberg Jenny, Feiner John R, Schober Andrew, Sall Jeffrey W, Eilers Helge, Bickler Philip E
1 Department of Anesthesia and Intensive Care, Institution for Clinical Science, Karolinska Institutet, Danderyds University Hospital , Stockholm, Sweden .
2 Department of Anesthesia and Perioperative Care, University of California San Francisco , San Francisco, California.
High Alt Med Biol. 2018 Sep;19(3):249-258. doi: 10.1089/ham.2017.0144. Epub 2018 Jun 20.
Lundeberg, Jenny, John R. Feiner, Andrew Schober, Jeffrey W. Sall, Helge Eilers, and Philip E. Bickler. Increased cytokines at high altitude: lack of effect of ibuprofen on acute mountain sickness, physiological variables or cytokine levels. High Alt Med Biol. 19:249-258, 2018.
There is no consensus on the role of inflammation in high-altitude acclimatization.
To determine the effects of a nonsteroidal anti-inflammatory drug (ibuprofen 400 mg every 8 hours) on blood cytokines, acclimatization, acute mountain sickness (AMS, Lake Louise Score), and noninvasive oxygenation in brain and muscle in healthy volunteers.
In this double-blind study, 20 volunteers were randomized to receive ibuprofen or placebo at sea level and for 48 hours at 3800 m altitude. Arterial, brain, and leg muscle saturation with near infrared spectroscopy, pulse oximetry, and heart rate were measured. Blood samples were collected for cytokine levels and cytokine gene expression.
All of the placebo subjects and 8 of 11 ibuprofen subjects developed AMS at altitude (p = 0.22, comparing placebo and ibuprofen). On arrival at altitude, the oxygen saturation as measured by pulse oximetry (SO) was 84.5% ± 5.4% (mean ± standard deviation). Increase in blood interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α), and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels occurred comparably in the placebo and ibuprofen groups (all not significant, univariate test by Wilcoxon rank sum). Increased IL-6 was associated with higher AMS scores (p = 0.002 by Spearman rank correlation). However, we found no difference or association in AMS score and blood or tissue oxygenation between the ibuprofen and placebo groups.
We found that ibuprofen, at the package-recommended adult dose, did not have a significant effect on altitude-related increases in cytokines, AMS scores, blood, or tissue oxygenation in a population of healthy subjects with a high incidence of AMS.
伦德伯格,珍妮,约翰·R·费纳,安德鲁·肖伯,杰弗里·W·萨尔,赫尔格·艾勒斯,以及菲利普·E·比克勒。高原地区细胞因子增加:布洛芬对急性高原病、生理变量或细胞因子水平无影响。《高原医学与生物学》。2018年第19卷:249 - 258页。
关于炎症在高原适应中的作用尚无共识。
确定一种非甾体抗炎药(布洛芬,每8小时400毫克)对健康志愿者血液中的细胞因子、适应、急性高原病(AMS,路易斯湖评分)以及大脑和肌肉的无创氧合的影响。
在这项双盲研究中,20名志愿者被随机分配在海平面接受布洛芬或安慰剂,并在海拔3800米处接受48小时治疗。通过近红外光谱、脉搏血氧饱和度测定法和心率测量动脉、大脑和腿部肌肉的饱和度。采集血样以检测细胞因子水平和细胞因子基因表达。
所有安慰剂组受试者和11名布洛芬组受试者中的8人在高原地区出现了急性高原病(比较安慰剂组和布洛芬组,p = 0.22)。到达高原时,通过脉搏血氧饱和度测定法(SO)测得的血氧饱和度为84.5%±5.4%(平均值±标准差)。安慰剂组和布洛芬组血液中白细胞介素 - 1β(IL - 1β)、白细胞介素 - 6(IL - 6)、白细胞介素 - 8(IL - 8)、白细胞介素 - 10(IL - 10)、肿瘤坏死因子 - α(TNF - α)和粒细胞 - 巨噬细胞集落刺激因子(GM - CSF)水平的升高情况相当(所有均无统计学意义,采用威尔科克森秩和检验进行单变量分析)。IL - 6升高与更高的急性高原病评分相关(斯皮尔曼等级相关分析,p = 0.002)。然而,我们发现布洛芬组和安慰剂组在急性高原病评分以及血液或组织氧合方面没有差异或关联。
我们发现,对于急性高原病发病率较高的健康受试者群体,按照包装推荐的成人剂量服用布洛芬,对高原相关的细胞因子增加、急性高原病评分、血液或组织氧合没有显著影响。